A $650 million programme set up by pharma group MSD to help prevent maternal mortality and improve health equity around the world has reached over 30 million women, easily outpacing its target of 25 million by 2025.
The MSD for Mothers campaign was launched more than a decade ago and has now supported more than 200 maternal healthcare programmes in over 70 countries. In the US and Canada, where MSD is known as Merck & Co, it runs under the Merck for Mothers banner.
